Skip to search.
 BSE Up0.19% NSE Up0.28%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS

12.69 Up 0.29(2.34%) 18 May 1:30AM|After Hours : 12.40 Down 0.29 (2.29%) 18 May 2:05AM

Add to Portfolio
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Avg. Estimate-0.22-0.24-0.95-1.01
No. of Analysts7.007.007.006.00
Low Estimate-0.23-0.28-1.04-1.19
High Estimate-0.21-0.22-0.86-0.81
Year Ago EPS-0.23-0.25-1.02-0.95
Revenue EstCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Avg. Estimate1.67M1.52M7.24M3.73M
No. of Analysts7776
Low Estimate100.00k40.00k2.70M50.00k
High Estimate3.50M3.50M12.91M14.00M
Year Ago Sales2.01M3.11M11.20M7.24M
Sales Growth (year/est)-16.90%-51.20%-35.40%-48.50%
Earnings HistoryJun 2012Sep 2012Dec 2012Mar 2013
EPS Est-0.25-0.24-0.25-0.22
EPS Actual-0.23-0.25-0.27-0.23
Difference0.02-0.01-0.02-0.01
Surprise %8.00%-4.20%-8.00%-4.50%
EPS TrendsCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Current Estimate-0.22-0.24-0.95-1.01
7 Days Ago-0.22-0.24-0.95-1.01
30 Days Ago-0.22-0.24-0.92-0.99
60 Days Ago-0.22-0.24-0.92-0.99
90 Days Ago-0.27-0.26-0.90-0.93
EPS RevisionsCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Up Last 7 Days0000
Up Last 30 Days3332
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstCLDXIndustrySectorS&P 500
Current Qtr.4.30%N/AN/A11.80%
Next Qtr.4.00%N/AN/A16.60%
This Year6.90%N/A9.70%9.10%
Next Year-6.30%N/A13.20%12.60%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A13.14%13.69%9.37%
Price/Earnings (avg. for comparison categories)-13.05-0.683.2113.29
PEG Ratio (avg. for comparison categories)N/A-5.56-0.681.32
Currency in USD.